Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 8,620.00
-320.00 (-3.58%)
Apr 30, 2026, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 396.92 billion as of April 30, 2026. Its market cap has increased by 264.48% in one year.
Market Cap
396.92B
Enterprise Value
314.81B
Revenue
2.60B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,620.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 396.92B, an increase of 66.33%. That is a compound annual growth rate of 2.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 396.92B | 38.59% |
| Dec 30, 2025 | 286.41B | 130.37% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GC Corp. | 643.80B |
| SillaJen | 502.10B |
| Genomictree | 456.92B |
| GC Cell | 377.93B |
| Anterogen.Co.,Ltd. | 372.23B |
| BINEX | 370.71B |
| HLB Therapeutics | 321.66B |
| Bioneer | 283.14B |